Mecobalamin + anti-VEGF combination trial protocol aims to enhance neuroprotection in retinal vein occlusion macular edema.
Adjuvant mecobalamin for anti-VEGF therapy in retinal vein occlusion: protocol of a single-centre, randomised, double-blinded controlled trial.
Abstract
A randomized, double-blind trial will evaluate oral mecobalamin as an adjuvant to conbercept for retinal vein occlusion-related macular edema in 120 patients over 6 months.